Eckert & Ziegler AG (EUZ.DE,EUZ.F) Friday revealed higher profit in the first half of the year, helped by good performances in the Medical Segment and Isotope Products segment. The company also reaffirmed its outlook for fiscal 2025. The provider of isotope technology for medical and industrial applications reported profit of 21.4 million euros or 1.02 euros per share in the first half of fiscal 2025. This was a 19 percent increase from last year's 18.0 million euros or 0.87 euro per share.
According to Eckert & Ziegler, pre-tax profit rose to 32.55 million euros from 29.64 million euros in the previous-year period.
Half-yearly revenues rose 2 percent to 148.80 million euros from 145.38 million euros in the same period a year ago. EBITDA for the first six months of 2025 climbed 10 percent to 41.0 million euros from 37.4 million euros last year.
Looking ahead, the company reaffirmed its fiscal 2025 outlook of sales of around 320 million euros and adjusted EBIT of around 78 million euros.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.